http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c96eee10f828b57fe806d666095a72e9
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Konopleva Marina Konopleva |
| name | Marina Konopleva |
| given-name | Marina |
| organization-name | Department of Leukemia The University of Texas MD Anderson Cancer Center Houston TX USA Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA 1Blood and Marrow Transplantation, Section of Molecular Hematology and Therapy and Departments of The University of Texas, MD Anderson Cancer Center, Houston, TX; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA From The University of Texas M.D. Anderson Cancer Center, Houston, TX; and Progenitor, Inc, Menlo Park, CA. Department of Hematology-Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, USA 2Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, The University of Texas M.D. Anderson Cancer Center, Houston, Texas Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, M.D. Anderson Cancer Center, University of Texas, Houston Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX, USA 1Department of Leukemia, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Section of Leukemia Biology Research, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. From the Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, Department of Biostatistics, and Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and the Department of Clinical Pathology, Juntendo University of Medicine, Tokyo, Japan. The University of Texas MD Anderson Cancer Center, Houston, TX; and Department of Stem Cell Transplantation and Cellular Therapy, Department of Leukemia,; Department of Stem Cell Transplantation, and 1Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston Texas.; 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston Texas. Departments of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA Section of Molecular Hematology and Therapy, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Leukemia and Authors' Affiliations: 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, 2Department of Leukemia, 3Department of Stem Cell Transplantation and Cellular Therapy, and 4Department of Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 5Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; 6Cancer Research Institute, M.D. Anderson Cancer Center Orlando, Orlando, Florida; 7Department of Biochemistry, University of Crete, School of Medicine, Heraklion, Greece; 8Reata Pharmaceuticals, Irving, Texas; and 9Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Authors' Affiliations: 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, 2Department of Leukemia, 3Department of Stem Cell Transplantation and Cellular Therapy, and 4Department of Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 5Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas; 6Cancer Research Institute, M.D. Anderson Cancer Center Orlando, Orlando, Florida; 7Department of Biochemistry, University of Crete, School of Medicine, Heraklion, Greece; 8Reata Pharmaceuticals, Irving, Texas; and 9Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada 2Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, Texas Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 1The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, Departments of; 2Leukemia and Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX; Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX From the Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, the Department of Leukemia, and the Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX. 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. From the Department of Blood and Marrow Transplantation, Section of Molecular Hematology and Therapy, and Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Department of Biochemistry, University of Illinois at Urbana-Champaign, Champaign, IL. 5Molecular Hematology and Therapy, University of Texas M. D. Anderson Cancer Center, Houston, Texas Section of Molecular Hematology and Therapy, University of Texas M. D. Anderson Cancer Center, Houston; Division of Cancer Medicine, Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, M. D. Anderson Cancer Center, The University of Texas, Houston, Texas 2Section of Leukemia Biological Research, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Leukemia University of Texas, MD Anderson Cancer Center Houston Texas 2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Leukemia University of Texas MD Anderson Cancer Center Houston Texas 11Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX From the Departments of Leukemia (N.J., M. Keating, P.T., A.F., J.B., G.B., K.T., Z.E., T.K., M. Konopleva, Y.A., M.Y., C.D., P.B., M.O., N.P., E.J., K. Sasaki, K. Sondermann, N.C., C.W., A.A., H.K., W.W.), Lymphoma and Myeloma (N.F.), Hematopathology (R.K.-S., K.P., J.J.), Diagnostic Radiology (N.G.), Biostatistics (X.W.), and Experimental Therapeutics (W.P., V.G.), University of Texas M.D. Anderson Cancer Center, Houston. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston TX USA; Department of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Houston TX USA From the Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Discovery Oncology, Roche Research Center, Hoffmann-La Roche Inc, Nutley, NJ. 1Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, The University of Texas M.D. Anderson Cancer Center; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center Texas USA Department of Oncology, Albert Einstein College of Medicine, Bronx, NY 10461, USA 14Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. From the University of Texas M.D. Anderson Cancer Center, Houston (N.P., M.D., H.M.K., M.K.); Dana–Farber Cancer Institute (A.A.L.) and Boston University School of Medicine (J.M.S.), Boston, and Veristat, Southborough (J.B.) — all in Massachusetts; H. Lee Moffitt Cancer Center, Tampa, FL (K.L.S., J.E.L.); City of Hope National Medical Center, Duarte, CA (A.S.S.); Ohio State University, Columbus (S.V.); Winship Cancer Institute of Emory University, Atlanta (W.B.); Duke University Medical Center, Durham,... Departments of Leukemia University of Texas, MD Anderson Cancer Center Houston TX 77015 USA Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston 3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas. 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; 4Department of Oncology, Montefiore Einstein Cancer Center & Albert Einstein College of Medicine, New York, NY Authors' Affiliations: 1Section of Molecular Hematology and Therapy; Departments of; 2Leukemia and 1Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation and Departments of Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Yuanqing Yan, Carlos Bueso-Ramos, Koji Sasaki, Ghayas C. Issa, Sa Wang, Jeffrey Jorgensen, Xingzhi Song, Jianhua Zhang, Samantha Tippen, Rebecca Thornton, Marcus Coyle, Latasha Little, Curtis Gumbs, Naveen Pemmaraju, Naval Daver, Courtney D. DiNardo, Marina Konopleva, Michael Andreeff, Farhad Ravandi, Jorge E. Cortes, Tapan Kadia, Elias Jabbour, Guillermo Garcia-Manero, Keyur P. Patel, P. Andrew Futreal, and Koichi Takahash, The University of Texas MD... From the Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, and the Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia M.D. Anderson Cancer Center Houston Texas USA Section of Molecular Hematology and Therapy, Department of Leukemia; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA Department of Leukemia, Section of Molecular Hematology and Therapy University of Texas MD Anderson Cancer Center Houston Texas Departments of Leukemia and; Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX;; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX 1The University of Texas MD Anderson Cancer Center, Houston, Texas. Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, and 2Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, and 2Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 1Blood and Marrow Transplantation and Departments of Division of Cancer Medicine, Department of Leukemia, MD Anderson Cancer Center University of Texas Houston Texas From the Department of Blood and Marrow Transplantation, Section of Molecular Hematology and Therapy, and the Departments of Bioimmunotherapy and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX; The University of Florida, Gainesville; Department of Medicine, Dartmouth College, Department of Chemistry and Dartmouth Medical School, Department of Pharmacology, Hanover, NH. *Hematology and Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA 3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Departments of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy,; 2Leukemia, Albert Einstein College of Medicine Departments of Leukemia and 1Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Authors' Affiliations: Departments of1Investigational Cancer Therapeutics (Phase I Clinical Trials Program), 2Leukemia, Division of Cancer Medicine, and 3Hematopathology, and 4Molecular Hematology and Therapy Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 5Reata Pharmaceuticals, Inc., Irving, Texas; 6Massachusetts General Hospital; 7Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Harvard Medical School; 8Early Drug Development Center, Department of Medical Oncology, Dana-Farber Cancer Institute; 9Dana-Farber Cancer Institute; 10Division of Hematology/Oncology, Massachusetts General Hospital; 11Department of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; and 12Department of Medicine, University Hospitals Case Medical Center, Cleveland, Ohio Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 1Blood and Marrow Transplantation, Section of Molecular Hematology and Therapy, Departments of Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Authors' Affiliations: 1Eutropics Pharmaceuticals, Cambridge, Massachusetts; 2Molecular Hematology and Therapy, Department of Stem Cell Transplantation; 3Division of Cancer Medicine, Department of Leukemia; and 4Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: 1Eutropics Pharmaceuticals, Cambridge, Massachusetts; 2Molecular Hematology and Therapy, Department of Stem Cell Transplantation; 3Division of Cancer Medicine, Department of Leukemia; and 4Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas Department of Leukemia,; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX Section of Molecular Hematology and Therapy, Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas; Department of Stem Cell Transplantation and Cellular Therapy The University of Texas MD Anderson Cancer Center Houston Texas From the Section of Molecular Hematology and Therapy, Departments of Blood and Marrow Transplantation, Biostatistics, and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Departments of Clinical Pathology and Biochemistry, Juntendo University of Medicine, Tokyo, Japan. UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 2Blood and Marrow Transplantation, University of Texas M.D. Anderson Cancer Center, Houston, Texas 1Blood and Marrow Transplantation, Departments of From The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA From the Departments of Leukemia and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX; and 4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 4The University of Texas MD Anderson Cancer Center, Houston, Texas. MD Anderson Cancer Center Houston Texas The University of Texas, MD Anderson Cancer Center Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Kathryn G. Roberts, Zhaohui Gu, Debbie Payne-Turner, Kelly McCastlain, Deqing Pei, Ilaria Iacobucci, Marcus Valentine, Stanley B. Pounds, Lei Shi, Yongjin Li, Jinghui Zhang, Cheng Cheng, and Charles G. Mullighan, St Jude Children’s Research Hospital, Memphis, TN; Richard C. Harvey, I-Ming Chen, and Cheryl L. Willman, University of New Mexico Cancer Center, Albuquerque, NM; Alessandro Rambaldi, Manuela Tosi, and Orietta Spinelli, Ospedale Papa Giovanni XXIII, Bergamo, Italy; Jerald P. Radich, Fred... Department of Leukemia The University of Texas—M.D. Anderson Cancer Center Houston Texas Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA Section of Molecular Hematology and Therapy, Department of Leukemia, Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX, USA; Department of Leukemia the University of Texas MD Anderson Cancer Center Houston Texas Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Department of Leukemia The University of Texas M.D. Anderson Cancer Center Houston TX USA Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX Section of Molecular Hematology & Therapy, Department of Leukemia, and; Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX The University of Texas M. D. Anderson Cancer Center, Houston; 1Section of Molecular Hematology and Therapy and the Departments of Blood and Marrow Transplantation, Department of Leukemia, Section of Molecular Hematology and Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas Authors' Affiliations: 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, 2Department of Leukemia, and 3Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center; 4The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas and 5Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University and Hospital, Taichung, Taiwan; Authors' Affiliations: 1Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, 2Department of Leukemia, and 3Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center; 4The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas and 5Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University and Hospital, Taichung, Taiwan Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA; 4The M.D. Anderson Cancer Center, Houston, Texas Division of Cancer Medicine – Unit 448, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston TX 77030, USA. Department of Blood and Marrow Transplantation, Section of Molecular Hematology and Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. Department of Leukemia MD Anderson Cancer Center Houston, TX USA Department of Leukemia, The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 1Section of Molecular Hematology and Therapy, Departments of Blood and Marrow Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX; Department of Blood and Marrow Transplantation, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Authors' Affiliations: Departments of 1Leukemia, 2Pediatrics, and 3Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 4Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; 6The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; 7AbbVie Inc., North Chicago, Illinois; and 8Department of Laboratory Medicine, University of California San Francisco, San Francisco, California; 9Department of Internal Medicine III, University Hospital of Ulm, Ulm; 10MLL Munich Leukemia Laboratory, Munich, Germany Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA From the Department of Leukemia, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (C.D.D., M.K.); the Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento (B.A.J.), the Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte (V. Pullarkat), and Genentech, South San Francisco (W.-J.H.) —... Section of Molecular Hematology and Therapy, Departments of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX; 2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Authors' Affiliations: 1Section of Molecular Hematology and Therapy, Department of Leukemia, 2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston; and 3AROG Pharmaceuticals LLC, Dallas, Texas; Authors' Affiliations: 1Section of Molecular Hematology and Therapy, Department of Leukemia, 2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston; and 3AROG Pharmaceuticals LLC, Dallas, Texas 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Leukemia, M. D. Anderson Cancer Center, Houston, TX, USA Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mkonople@mdanderson.org. 3Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, 1Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas. |
Incoming Links
Total number of triples: 610.